78% of physicians do not agree with government recommendations for mammography: HCD study

Results from a new media study among 600 physicians revealed that the majority (78%) reported that they do not agree with the new guidelines released by the Preventive Services Task Force of the Department of Health and Human Services recommending against regular mammography tests for women under 50 years old.

The study was conducted by HCD Research on November 18-19, to determine doctors' opinions on the new guidelines released earlier this week that do not recommend regular mammograms for women under 50. To view detailed results go to: www.hcdi.net or www.mediacurves.com.

In addition, the majority of physicians (78%) also reported that the advice they give to patients will not change based on the new Preventive Services Task Force of the Department of Health and Human Services guidelines.

Among the findings:

The new government recommendations, released by the Preventive Services Task Force of the Department of Health and Human Services, recommend against regular mammography tests for women under 50 years old. Do you agree with this new recommendation?

Total ----- Yes 22% --- -- No 78% -- --

Will the advice that you give to patients change based on these new guidelines?

Total ----- Yes 22% --- -- No 78% -- --

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy